Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Immunology test
ADR ID BADD_A06091
ADR Hierarchy
13      Investigations
13.06      Immunology and allergy investigations
13.06.03      Immunology analyses NEC
13.06.03.007      Immunology test
Description A medical specialty concerned with the hypersensitivity of the individual to foreign substances and protection from the resultant infection or disorder. [MeSH]
MedDRA Code 10062297
MeSH ID D000486; D005455; D004797; D019085; D019084
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Immune status | Immunology | Immunofluorescence | Western blot test | Enzyme-linked immunosorbent assay | ELISA | Direct immunofluorescence | Indirect immunofluorescence | Immunology test | Immunofixation | Allergy and Immunology | Immunology, Allergy | Allergy, Immunology | Immunology and Allergy | Allergy Specialty | Specialty, Allergy
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00053Albiglutide--
BADD_D00282Blinatumomab--
BADD_D00290Botulinum toxin type a--
BADD_D00561Cytarabine hydrochloride--
BADD_D00685Dinutuximab--
BADD_D00723Doxorubicin--
BADD_D00733Dulaglutide--
BADD_D00758Elosulfase alfa--
BADD_D00859Evolocumab--
BADD_D01298Liraglutide--
BADD_D01369Mefloquine--
BADD_D01474Mipomersen sodium--
BADD_D01996Sebelipase alfa--
The 1th Page    1    Total 1 Pages